YILDIZ TUTUNCU

Prof. YILDIZ TUTUNCU

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2013 in European Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
ISIlhan Satman
Ilhan Satman
BOBeyhan Omer
Beyhan Omer
YTYILDIZ TUTUNCU
YILDIZ TUTUNCU
SKSibel Kalaca
Sibel Kalaca
SGSelda Gedik
Selda Gedik
JTJaakko Tuomilehto
Jaakko Tuomilehto
There is concern about an emerging diabetes epidemic in Turkey. We aimed to determine the prevalence of diagnosed and undiagnosed diabetes, prediabetes and their 12-year trends and to identify risk factors for diabetes in the adult Turkish population. A cross-sectional, population-based survey, ‘TURDEP-II’ included 26,499 randomly sampled adults aged ≥ 20 years (response rate: 87 %). Fasting glucose and biochemical parameters were measured in all; then a OGTT was performed to identify diabetes and prediabetes in eligible participants. The prevalence of diabetes was 16.5 % (new 7.5 %), translating to 6.5 million adults with diabetes in Turkey. It was higher in women than men (p = 0.008). The age-standardized prevalence to the TURDEP-I population (performed in 1997–98) was 13.7 % (if same diagnostic definition was applied diabetes prevalence is calculated 11.4 %). The prevalence of isolated-IFG and impaired glucose tolerance (IGT), and combined prediabetes was 14.7, 7.9, and 8.2 %, respectively; and that of obesity 36 % and hypertension 31.4 %. Compared to TURDEP-I; the rate of increase for diabetes: 90 %, IGT: 106 %, obesity: 40 % and central obesity: 35 %, but hypertension decreased by 11 % during the last 12 years. In women age, waist, body mass index (BMI), hypertension, low education, and living environment; in men age, BMI, and hypertension were independently associated with an increased prevalence of diabetes. In women current smoking, and in men being single were associated with a reduced risk. These results from one of the largest nationally representative surveys carried out so far show that diabetes has rapidly become a major public health challenge in Turkey. The figures are alarming and underscore the urgent need for national programs to prevent diabetes, to manage the illness and thus prevent complications.

1 September 2002 in Diabetes Care
Verified
Journal Article
Open access
PDF file
ISIlhan Satman
Ilhan Satman
TYTemel Yilmaz
Temel Yilmaz
ASAhmet Sengül
Ahmet Sengül
SSSerpil Salman
Serpil Salman
FSFatih Salman
Fatih Salman
HKHilary King
Hilary King
OBJECTIVES—To investigate for the first time the prevalence of diabetes and impaired glucose tolerance (IGT) nationwide in Turkey; to assess regional variations and relationships between glucose intolerance and lifestyle and physical risk factors. RESEARCH DESIGN AND METHODS—The Turkish Diabetes Epidemiology Study (TURDEP) is a cross-sectional, population-based survey that included 24,788 subjects (age ≥20 years, women 55%, response 85%). Glucose tolerance was classified according to World Health Organization recommendations on the basis of 2-h blood glucose values. RESULTS—Crude prevalence of diabetes was 7.2% (previously undiagnosed, 2.3%) and of IGT, 6.7% (age-standardized to world and European populations, 7.9 and 7.0%). Both were more frequent in women than men (P < 0.0001) and in those living in urban rather than rural communities (P < 0.001). Prevalence rates of hypertension and obesity were 29 and 22%, respectively. Both were more common among women than men (P < 0.0001). Prevalence of diabetes and IGT increased with rising BMI, waist-to-hip ratio (WHR), and waist girth (P < 0.0001). Multiple logistic regression analysis revealed that age, BMI, WHR, familial diabetes, and hypertension were independently associated with diabetes, age, BMI, WHR, familial diabetes, and hypertension with IGT (except for familial diabetes in women with IGT). Education was related to diabetes in men but was protective for diabetes and IGT in women. Socioeconomic status appeared to decrease the risk of IGT in men while it increased the risk in women. Smoking had a protective effect for IGT in both sexes. CONCLUSIONS—Diabetes and IGT are moderately common in Turkey by international standards. Associations with obesity and hypertension have been confirmed. Other lifestyle factors had a variable relationship with glucose tolerance.

5 September 2011 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
PDF file
ACAyten Can
Ayten Can
SBSeldag Bekpinar
Seldag Bekpinar
FGFigen Gurdol
Figen Gurdol
YTYILDIZ TUTUNCU
YILDIZ TUTUNCU
YUYesim Unlucerci
Yesim Unlucerci
NDNevin Dinccag
Nevin Dinccag

1 April 2014 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
AUAyşe Kubat Uzum
Ayşe Kubat Uzum
MAMunevver Mertsoylu Aydin
Munevver Mertsoylu Aydin
YTYILDIZ TUTUNCU
YILDIZ TUTUNCU
BOBeyhan Omer
Beyhan Omer
EKEsen Kiyan
Esen Kiyan
FAFaruk Alagol
Faruk Alagol

28 December 2015 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
YTYILDIZ TUTUNCU
YILDIZ TUTUNCU
ISIlhan Satman
Ilhan Satman
SCSelda Celik
Selda Celik
NDNevin Dinccag
Nevin Dinccag
KKKubilay Karsidag
Kubilay Karsidag
BOBeyhan Omer
Beyhan Omer
Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) have been used to diagnose new-onset diabetes mellitus (DM) in order to simplify the diagnostic tests compared with the 2-hour oral glucose tolerance test (OGTT; 2-hPG). We aimed to identify optimal cut-off points of high sensitive C-reactive protein (hs-CRP) in new-onset DM people based on FPG, 2-hPG, or HbA1c methods. Data derived from recent population-based survey in Turkey (TURDEP-II). The study included 26,499 adult people (63% women, response rate 85%). The mean serum concentration of hs-CRP in women was higher than in men (p<0.001). The people with new-onset DM based on HbA1c had higher mean hs-CRP level than FPG based and 2-hPG based DM cases. In HbA1c, 2-hPG, and FPG based new-onset DM people, cut-off levels of hs-CRP in women were 2.9, 2.1, and 2.5 mg/L [27.5, 19.7, and 23.5 nmol/L] and corresponding values in men were 2.0, 1.8, and 1.8 mg/L (19.0, 16.9, and 16.9 nmol/L), respectively (sensitivity 60–65% and specificity 54–64%). Our results revealed that hs-CRP may not further strengthen the diagnosis of new-onset DM. Nevertheless, the highest hs-CRP level observed in new-onset DM people diagnosed with HbA1c criterion supports the general assumption that this method might recognize people in more advanced diabetic stage compared with other diagnostic methods.

1 June 2007 in Human Immunology
Verified
Journal Article
Closed access
VYVuslat Yilmaz
Vuslat Yilmaz
YTYILDIZ TUTUNCU
YILDIZ TUTUNCU
NHN. Barış Hasbal
N. Barış Hasbal
YPYesim Parman
Yesim Parman
PSPiraye Serdaroglu
Piraye Serdaroglu
GSGüher Saruhan-Direskeneli
Güher Saruhan-Direskeneli